Markus J. van Roosmalen

3.6k citations

26 papers · 1.1k indexed · h-index 17

Co-authors: Wigard P. Kloosterman Edwin Cuppen Ivo Renkens Emile E. Voest Jose Espejo Valle-Inclán Masoumeh Tavakoli‐Yaraki Sjors Middelkamp Marco J. Koudijs
Topics: Cancer Genomics and Diagnostics (13 papers)Genomic variations and chromosomal abnormalities (6 papers)Genomics and Rare Diseases (4 papers)
Cited by: Cancer Research Genetics Molecular Biology
Journals: Nature Communications Blood Cancer Research
Partner nations: Netherlands Germany United States

In The Last Decade

Markus J. van Roosmalen

24 papers receiving 1.0k citations

Peers

Countries citing papers authored by Markus J. van Roosmalen

Since Specialization

Citations

This map shows the geographic impact of Markus J. van Roosmalen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus J. van Roosmalen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus J. van Roosmalen more than expected).

Fields of papers citing papers by Markus J. van Roosmalen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus J. van Roosmalen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus J. van Roosmalen. The network helps show where Markus J. van Roosmalen may publish in the future.

Co-authorship network of co-authors of Markus J. van Roosmalen

This figure shows the co-authorship network connecting the top 25 collaborators of Markus J. van Roosmalen. A scholar is included among the top collaborators of Markus J. van Roosmalen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus J. van Roosmalen. Markus J. van Roosmalen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells 2025 ·Cancer Discovery ·(unknown),Carolina Velázquez,(unknown),(unknown),Markus J. van Roosmalen,Axel Rosendahl Huber,(unknown),Wouter Bossuyt,Bernard Thienpont,Thierry Voet,Kristel Van Calsteren,Liesbeth Lenaerts,Ruben van Boxtel,Frédéric Amant	0
2	Direct detection of 8-oxo-dG using nanopore sequencing 2025 ·Nature Communications ·Marc Pagès-Gallego,(unknown),Nicolle Besselink,Roy Straver,(unknown),Carlo Vermeulen,Alessio Marcozzi,Markus J. van Roosmalen,Ruben van Boxtel,Boudewijn Burgering,Tobias B. Dansen,Jeroen de Ridder	2
3	Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms 2024 ·Nature Communications ·(unknown),Jurrian K. de Kanter,(unknown),Mark Verheul,(unknown),Markus J. van Roosmalen,Henrik Hasle,(unknown),Dirk Reinhardt,Michael Dworzak,Nora Mühlegger,Marry M. van den Heuvel‐Eibrink,C. Michel Zwaan,Bianca F. Goemans,Ruben van Boxtel	8
4	Mitochondrial H2O2 release does not directly cause damage to chromosomal DNA 2024 ·Nature Communications ·(unknown),Paulien E. Polderman,(unknown),(unknown),Markus J. van Roosmalen,(unknown),Johannes Lehmann,(unknown),Sasha De Henau,Ruben van Boxtel,Boudewijn Burgering,Tobias B. Dansen	27
5	Transient Differentiation-State Plasticity Occurs during Acute Lymphoblastic Leukemia Initiation 2024 ·Cancer Research ·(unknown),(unknown),Markus J. van Roosmalen,(unknown),Jessica G. C. A. M. Buijs-Gladdines,Bram van Wijk,Jules P.P. Meijerink,Ruben van Boxtel	2
6	MutationalPatterns: the one stop shop for the analysis of mutational processes 2022 ·BMC Genomics ·Freek Manders,Arianne M. Brandsma,Jurrian K. de Kanter,Mark Verheul,Rurika Oka,Markus J. van Roosmalen,Bastiaan van der Roest,Arne van Hoeck,Edwin Cuppen,Ruben van Boxtel	88
7	Elevated Mutational Age in Blood of Children Treated for Cancer Contributes to Therapy-Related Myeloid Neoplasms 2022 ·Cancer Discovery ·(unknown),Axel Rosendahl Huber,Jurrian K. de Kanter,Arianne M. Brandsma,(unknown),Mark Verheul,Marry M. van den Heuvel‐Eibrink,Rurika Oka,Markus J. van Roosmalen,Hester A. de Groot‐Kruseman,C. Michel Zwaan,Bianca F. Goemans,Ruben van Boxtel	16
8	Human induced pluripotent stem cells display a similar mutation burden as embryonic pluripotent cells in vivo 2022 ·iScience ·(unknown),Freek Manders,(unknown),Mark Verheul,Markus J. van Roosmalen,(unknown),Rurika Oka,Ewart Kuijk,Susana M. Chuva de Sousa Lopes,Ruben van Boxtel	7
9	A multi-platform reference for somatic structural variation detection 2022 ·Cell Genomics ·Jose Espejo Valle-Inclán,Nicolle Besselink,Ewart de Bruijn,Daniel Cameron,Jana Ebler,Joachim Kutzera,Stef van Lieshout,Tobias Marschall,Marcel Nelen,Peter Priestley,Ivo Renkens,Margaretha G.M. Roemer,Markus J. van Roosmalen,Aaron M. Wenger,Bauke Ylstra,Remond J.A. Fijneman,Wigard P. Kloosterman,Edwin Cuppen	17
10	Mutation Signatures of Pediatric Acute Myeloid Leukemia and Normal Blood Progenitors Associated with Differential Patient Outcomes 2021 ·Blood Cancer Discovery ·Arianne M. Brandsma,(unknown),Markus J. van Roosmalen,(unknown),Rurika Oka,Mark Verheul,Freek Manders,(unknown),Mirjam E. Belderbos,Ruben van Boxtel	18
11	Diverse BRAF Gene Fusions Confer Resistance to EGFR-Targeted Therapy via Differential Modulation of BRAF Activity 2020 ·Molecular Cancer Research ·(unknown),(unknown),Markus J. van Roosmalen,Nizar Hami,Ingrid Verlaan-Klink,Harmjan R. Vos,Robert M. van Es,Marco J. Koudijs,Emile E. Voest,Hugo J.G. Snippert,Wigard P. Kloosterman	11
12	Partner independent fusion gene detection by multiplexed CRISPR-Cas9 enrichment and long read nanopore sequencing 2020 ·Nature Communications ·(unknown),Sam de Blank,Ivo Renkens,Liset Westera,(unknown),Jose Espejo Valle-Inclán,Rocío Chamorro González,Anton G. Henssen,Markus J. van Roosmalen,Ronald W. Stam,Emile E. Voest,Wigard P. Kloosterman,Gijs van Haaften,Glen R. Monroe	47
13	Prioritization of genes driving congenital phenotypes of patients with de novo genomic structural variants 2019 ·Genome Medicine ·Sjors Middelkamp,(unknown),Jacques C. Giltay,Jerome Korzelius,Nicolle Besselink,Sander Boymans,Roel Janssen,(unknown),Ellen van Binsbergen,Markus J. van Roosmalen,Ron Hochstenbach,Daniela Giachino,Michael E. Talkowski,Wigard P. Kloosterman,Edwin Cuppen	17
14	A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer 2017 ·Cancer Research ·Wigard P. Kloosterman,Robert R.J. Coebergh van den Braak,Mark Pieterse,Markus J. van Roosmalen,Anieta M. Sieuwerts,(unknown),(unknown),Zarina S. Lalmahomed,Salo Ooft,Anne van Galen,Marcel Smid,(unknown),Fried Zwartkruis,John W.M. Martens,John A. Foekens,Katharina Biermann,Marco J. Koudijs,Jan N.M. IJzermans,Emile E. Voest	67
15	Mapping and phasing of structural variation in patient genomes using nanopore sequencing 2017 ·Nature Communications ·(unknown),Markus J. van Roosmalen,Ivo Renkens,Marleen M. Nieboer,Sjors Middelkamp,Joep de Ligt,Giulia Pregno,Daniela Giachino,Giorgia Mandrile,Jose Espejo Valle-Inclán,Jerome Korzelius,Ewart de Bruijn,Edwin Cuppen,Michael E. Talkowski,Tobias Marschall,Jeroen de Ridder,Wigard P. Kloosterman	249
16	Molecular dissection of germline chromothripsis in a developmental context using patient-derived iPS cells 2017 ·Genome Medicine ·Sjors Middelkamp,Sebastiaan van Heesch,A. Koen Braat,Joep de Ligt,Maarten van Iterson,Marieke Simonis,Markus J. van Roosmalen,Martijn J. E. Kelder,Evelien Kruisselbrink,Ron Hochstenbach,Nienke E. Verbeek,Elly F. Ippel,Youri Adolfs,R. Jeroen Pasterkamp,Wigard P. Kloosterman,Ewart Kuijk,Edwin Cuppen	25
17	Chromothripsis in Healthy Individuals Affects Multiple Protein-Coding Genes and Can Result in Severe Congenital Abnormalities in Offspring 2015 ·The American Journal of Human Genetics ·Mirjam S. de Pagter,Markus J. van Roosmalen,Annette F. Baas,Ivo Renkens,Karen Duran,Ellen van Binsbergen,Masoumeh Tavakoli‐Yaraki,Ron Hochstenbach,Lars T. van der Veken,Edwin Cuppen,Wigard P. Kloosterman	80
18	Genomic and transcriptomic plasticity in treatment-naïve ovarian cancer 2013 ·Genome Research ·Marlous Hoogstraat,Mirjam S. de Pagter,Geert A. Cirkel,Markus J. van Roosmalen,Timothy T. Harkins,Karen Duran,(unknown),Ivo Renkens,Petronella O. Witteveen,Clarence Lee,Isaäc J. Nijman,(unknown),Ruben van ‘t Slot,Trudy N. Jonges,Martijn P. Lolkema,Marco J. Koudijs,Ronald P. Zweemer,Emile E. Voest,Edwin Cuppen,Wigard P. Kloosterman	63
19	Mate pair sequencing for the detection of chromosomal aberrations in patients with intellectual disability and congenital malformations 2013 ·European Journal of Human Genetics ·Sarah Vergult,Ellen van Binsbergen,Tom Sante,(unknown),Olivier Vanakker,Kathleen Claes,Bruce Poppe,Nathalie Van der Aa,Markus J. van Roosmalen,Karen Duran,Masoumeh Tavakoli‐Yaraki,Mariëlle E.M. Swinkels,Marie-José van den Boogaard,Mieke M. van Haelst,Filip Roelens,Frank Speleman,Edwin Cuppen,Geert Mortier,Wigard P. Kloosterman,Björn Menten	25
20	Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer 2011 ·Genome biology ·Wigard P. Kloosterman,Marlous Hoogstraat,(unknown),Masoumeh Tavakoli‐Yaraki,Ivo Renkens,Joost S.P. Vermaat,Markus J. van Roosmalen,Stef van Lieshout,Isaäc J. Nijman,Wijnand Roessingh,Ruben van ‘t Slot,José van de Belt,Victor Guryev,Marco J. Koudijs,Emile E. Voest,Edwin Cuppen	161

About Markus J. van Roosmalen

Markus J. van Roosmalen is a scholar working on Cancer Research, Hematology and Genetics, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (13 papers), Genomic variations and chromosomal abnormalities (6 papers) and Genomics and Rare Diseases (4 papers). The work is most often cited by research in Cancer Research (344 citations), Genetics (352 citations) and Molecular Biology (650 citations). Markus J. van Roosmalen has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Wigard P. Kloosterman, Edwin Cuppen, Ivo Renkens, Emile E. Voest, Jose Espejo Valle-Inclán, Masoumeh Tavakoli‐Yaraki, Sjors Middelkamp, Marco J. Koudijs, Ruben van Boxtel and Michael E. Talkowski. Their work appears in journals such as Nature Communications, Blood and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact